A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study.

Source:http://linkedlifedata.com/resource/pubmed/id/19438397

Clin. Infect. Dis. 2009 Jun 15 48 12 1752-9

Download in:

View as

General Info

PMID
19438397